- Home
- ASYS vs ACRV Comparison
ASYS vs ACRV Comparison
Compare ASYS & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- ACRV
- Stock Information
- Founded
- ASYS 1981
- ACRV 2018
- Country
- ASYS United States
- ACRV United States
- Employees
- ASYS N/A
- ACRV N/A
- Industry
- ASYS Industrial Machinery/Components
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- ASYS Technology
- ACRV Health Care
- Exchange
- ASYS Nasdaq
- ACRV Nasdaq
- Market Cap
- ASYS 70.3M
- ACRV 73.5M
- IPO Year
- ASYS N/A
- ACRV 2022
- Fundamental
- Price
- ASYS $4.81
- ACRV $1.68
- Analyst Decision
- ASYS
- ACRV Strong Buy
- Analyst Count
- ASYS 0
- ACRV 6
- Target Price
- ASYS N/A
- ACRV $21.80
- AVG Volume (30 Days)
- ASYS 70.8K
- ACRV 200.8K
- Earning Date
- ASYS 05-07-2025
- ACRV 05-13-2025
- Dividend Yield
- ASYS N/A
- ACRV N/A
- EPS Growth
- ASYS N/A
- ACRV N/A
- EPS
- ASYS 0.08
- ACRV N/A
- Revenue
- ASYS $100,679,000.00
- ACRV N/A
- Revenue This Year
- ASYS N/A
- ACRV N/A
- Revenue Next Year
- ASYS $27.04
- ACRV N/A
- P/E Ratio
- ASYS $61.11
- ACRV N/A
- Revenue Growth
- ASYS N/A
- ACRV N/A
- 52 Week Low
- ASYS $4.60
- ACRV $1.56
- 52 Week High
- ASYS $6.96
- ACRV $11.90
- Technical
- Relative Strength Index (RSI)
- ASYS 41.99
- ACRV 19.94
- Support Level
- ASYS $4.83
- ACRV $5.00
- Resistance Level
- ASYS $5.17
- ACRV $5.65
- Average True Range (ATR)
- ASYS 0.20
- ACRV 0.45
- MACD
- ASYS -0.00
- ACRV -0.40
- Stochastic Oscillator
- ASYS 18.33
- ACRV 2.93
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.